Experimental study of the efficacy of daptomycin for the treatment of cephalosporin-resistant pneumococcal meningitis

Journal of Antimicrobial Chemotherapy

Volumn 69, Issue 11, 2014, Pages 3020-3026

  Vivas, M ^a   Force, E ^a   Garrigos C ^a   Tubau, F ^b   Platteel, A C M ^a   Ariza, J ^a   Cabellos, C ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

CNS infections; Lipopeptides; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; CEPHALOSPORIN; DAPTOMYCIN; VANCOMYCIN; CEPHALOSPORIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFICACY; DRUG PENETRATION; EXPERIMENTAL STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NEW ZEALAND WHITE (RABBIT); NONHUMAN; PHARMACOKINETIC PARAMETERS; PNEUMOCOCCAL MENINGITIS; SINGLE DRUG DOSE; TREATMENT RESPONSE; ANIMAL; CEREBROSPINAL FLUID; DRUG EFFECTS; MENINGITIS, PNEUMOCOCCAL; RABBIT; TREATMENT OUTCOME;

ANIMALS; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; DAPTOMYCIN; FEMALE; MENINGITIS, PNEUMOCOCCAL; RABBITS; TREATMENT OUTCOME;

EID: 84931428406     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku231     Document Type: Article

References (34)

1. Shin SH, Kim KS. Treatment of bacterial meningitis: an update. Expert Opin Pharmacother 2012; 15: 2189-206.
2. Kasanmoentalib ES, Brouwer MC, van de Beek D. Update on bacterial meningitis: epidemiology, trials and genetic association studies. Curr Opin Neurol 2013; 3: 282-8.
3. Weisfelt M, de Gans J, van der Poll T et al. Pneumococcal meningitis in adults: new approaches to management and prevention. Lancet Neurol 2006; 4: 332-42.
4. Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 2010; 23: 467-92.
5. Liñares J, Ardanuy C, Pallares R et al. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect 2010; 16: 402-10.
6. Viladrich PF, Cabellos C, Pallares R et al. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1996; 40: 218-20.
7. Lonks JR, Durkin MR, Meyerhoff AN et al. Meningitis due to ceftriaxoneresistant Streptococcus pneumoniae. New Engl J Med 1995; 332: 893-4.
8. Sloas MM, Barrett FF, Chesney PJ et al. Cephalosporin treatment failure in penicillin-and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J 1992; 11: 662-6.
9. Force E, Taberner F, Cabellos C et al. Experimental study of meropenem in the therapy of cephalosporin-susceptible and-resistant pneumococcal meningitis. Eur J Clin Microbiol Infect Dis 2008; 8: 685-90.
10. Ribes S, Taberner F, Domenech A et al. Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916. J Antimicrob Chemother 2005; 5: 979-82.
11. Ribes S, Taberner F, Domenech A et al. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae. J Antimicrob Chemother 2006; 5: 931-6.
12. Fernández A, Cabellos C, Tubau F et al. Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis. J Antimicrob Chemother 2005; 1: 78-83.
13. Domenech A, Cabellos C, Ribes S et al. Experimental study of clinafloxacin alone and in combination in the treatment of ciprofloxacin-susceptible and-resistant pneumococcal meningitis. Microb Drug Resist 2003; 9 Suppl 1: S53-9.
14. Cottagnoud P, Acosta F, Cottagnoud M et al. Synergy between trovafloxacin and ceftriaxone against penicillin-resistant pneumococci in the rabbit meningitis model and in vitro. Antimicrob Agents Chemother 2000; 8: 2179-81.
15. Cilli F, Aydemir S, Tunger A. In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci. J Chemother 2006; 18: 27-32.
16. Piper KE, Steckelberg JM, Patel R. In vitro activity of daptomycin against clinical isolates of Gram-positive bacteria. J Infect Chemother 2005; 11: 207-9.
17. Garrigós C, Murillo O, Lora-Tamayo J et al. Efficacy of daptomycin-cloxacillin combination in experimental foreign-body infection due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2012; 56: 3806-11.
18. Miró JM, García-de-la-Mària C, Armero Yet al. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009; 53: 4172-7.
19. McGee L, McDougal L, Zhou J et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the pneumococcal molecular epidemiology network. J Clin Microbiol 2001; 39: 2565-71.
20. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA, 2000.
21. National Committee for Clinical Laboratory Standards. Methods for Determining Bactericidal Activity of Antimicrobial Agents: Approved Guideline M26-A. NCCLS, Wayne, PA, USA, 1999.
22. Eliopoulos GM, Moellering RC Jr. Antimicrobial combinations. In: Lorian V, ed. Antibiotics in Laboratory Medicine, 4th edn. Baltimore, MD: Williams & Wilkins Co., 1996; 330-6.
23. Garrigós C, Murillo O, Euba G et al. Efficacy of tigecycline alone and with rifampin in foreign-body infection by methicillin-resistant Staphylococcus aureus. J Infect 2011; 63: 229-35.
24. Dacey RG, Sande MA. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother 1974; 6: 437-41.
25. Ribes S, Domenech A, Cabellos C et al. Experimental meningitis due to a high-level cephalosporin-resistant strain of Streptococcus pneumoniae serotype 23F. Enferm Infecc Microbiol Clin 2003; 21: 329-33.
26. Martinez-Lacasa J, Cabellos C, Martos A et al. Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. J Antimicrob Chemother 2002; 49: 507-13.
27. Cabellos C, Martinez-Lacasa J, Tubau F et al. Evaluation of combined ceftriaxone and dexamethasone therapy in experimental cephalosporinresistant pneumococcal meningitis. J Antimicrob Chemother 2000; 45: 315-20.
28. Chapin-Robertson K, Edberg SC. Measurements of antibiotics in human body fluids: techniques and significance. In: Lorian V, ed. Antibiotics in Laboratory Medicine. New York, NY: Williams and Wilkins, 1991; 295-366.
29. Schaad UB, Suter S, Gianella-Borradori A et al. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. New Engl J Med 1990; 3: 141-7.
30. Grandgirard D, Oberson K, Bühlmann A et al. Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis. Antimicrob Agents Chemother 2010; 54: 1323-6.
31. Grandgirard D, Burri M, Agyeman P et al. Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis. Antimicrob Agents Chemother 2012; 56: 4289-95.
32. Cottagnoud P, Pfister M, Acosta F et al. Daptomycin is highly efficacious against penicillin-resistant and penicillin-and quinolone-resistant pneumococci in experimental meningitis. Antimicrob Agents Chemother 2004; 10: 3928-33.
33. Le J, Bookstaver PB, Rudisill CN et al. Treatment of meningitis caused by vancomycin-resistant Enterococcus faecium: high-dose and combination daptomycin therapy. Ann Pharmacother 2010; 44: 2001-6.
34. Egermann U, Stanga Z, Ramin A et al. Combination of daptomycin plus ceftriaxone is more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone. Antimicrob Agents Chemother 2009; 7: 3030-3.